USP Ofloxacin Related Compound A RS [9-fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid] .
USP Oleoyl Polyoxylglycerides RS .
USP Omeprazole Related Compound A RS [(omeprazole sulfone, 5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfonyl]-1H-benzimidazole)] (C17H19N3O4S 361.42 CAS-88546-55-8).
USP Ondansetron Related Compound A RS [3[(dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one] .
USP Ondansetron Related Compound B RS [6,6¢-methylene bis-[(1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)-methyl]-4H-carbazol-4-one] .
USP Ondansetron Resolution Mixture RS Ondansetron hydrochloride having approximately 0.4% w/w of both ondansetron related compound A and 6,6¢-methylene bis-[(1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)-methyl]-4H-carbazol-4-one)].
USP Orphenadrine Citrate RS .
USP Oxacillin Sodium RS .
USP Oxandrolone Related Compound A RS [(7,8-didehydro-oxandrolone) or (17-hydroxy-17-methyl-2-oxa-5-androst-7-en-3-one)].
USP Oxandrolone Related Compound B RS [(anhydro-oxandrolone) or (17-17-dimethyl-2-oxa-18-nor-5-androstan-3-one)].
USP Oxandrolone Related Compound C RS [anhydro-oxandrolone (17,17-dimethyl-2-oxa-18-nor-5-androstan-3-one)] .
USP Oxprenolol Hydrochloride RS .
USP Oxtriphylline RS .
USP Oxybutynin Related Compound B RS [methyl ester of phenylcyclohexylglycolic acid, or CHMME (cyclohexyl mandelic acid methyl ester)] .
USP Oxybutynin Related Compound C RS [methylethyl analog of oxybutynin chloride, or (4-(ethylmethylamino) but-2-ynyl (±) 2-cyclohexyl-2-hydroxy-2-phenylacetate hydrochloride)] .
USP OxygenHelium RS.
USP Oxyquinoline Sulfate RS .
USP Oxytetracycline RS .